Onderneming Ceapro Inc. Other OTC
Aandelen
CRPOF
CA1499071076
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Active Ingredient Product Technology
100,0
%
| 19 | 100,0 % | 10 | 100,0 % | -48,87% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Germany
49,9
%
| 6 | 31,5 % | 5 | 49,9 % | -19,00% |
United States
47,8
%
| 11 | 58,8 % | 5 | 47,8 % | -58,41% |
Other
1,8
%
| 0 | 0,4 % | 0 | 1,8 % | +153,54% |
Canada
0,3
%
| 0 | 0,2 % | 0 | 0,3 % | -15,21% |
China
0,1
%
| 2 | 9,2 % | 0 | 0,1 % | -99,38% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 01-01-07 |
Director of Finance/CFO | - | 05-05-15 | |
Mitch Regnier
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-23 |
Paul Moquin
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-18 |
Chief Tech/Sci/R&D Officer | - | 01-01-10 | |
General Counsel | - | - | |
Leoni DeJoya
PRN | Corporate Officer/Principal | - | 07-01-19 |
52 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 01-01-07 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 27-04-15 |
William Li
BRD | Director/Board Member | 61 | 20-11-14 |
Ronald Miller
CHM | Chairman | - | 02-03-22 |
Geneviève Foster
BRD | Director/Board Member | - | 19-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 78 293 177 | 75 156 073 ( 95,99 %) | 0 | 95,99 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |